| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Financial Officer
3 companies
Tomsicek Michael John is a Director at MIST, with reported holdings spanning 3 companies. Recent filings cover 1 purchase and 7 sales. Those positions are worth an estimated $341K at current prices.
Tomsicek Michael John's largest disclosed position is in CRSP as Chief Financial Officer, worth about $261K. The recent filings there lean toward selling, a net 49,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 19, 2022 | MIST Milestone Pharmaceuticals Inc. | Director | Buy | 15,000 | $5.32 | $79,800.00 | New | -21.0% | -44.6% | |
| Aug 6, 2021 | CRSP Crispr Therapeutics AG | Chief Financial Officer | Sale+OE | 25,000 | $138.52 | $3,462,926.36 | -93.0% | -32.0% | -40.5% | |
| Sep 1, 2020 | CRSP Crispr Therapeutics AG | Chief Financial Officer | Sale+OE | 12,000 | $92.26 | $1,107,068.00 | -96.7% | - | - | |
| Aug 3, 2020 | CRSP Crispr Therapeutics AG | Chief Financial Officer | Sale+OE | 12,000 | $86.74 | $1,040,918.53 | -96.7% | - | - |